TET2 and myeloid neoplasm: TET2 mutations have been observed to co-occur with NPM1, FLT3-ITD, JAK2, ASXL1, calreticulin (CALR), SF3B1 and RUNX1 revealing the range of epigenetic connections to cellular processes amongst various myeloid malignancies [40].